Copyright
©The Author(s) 2022.
World J Gastroenterol. Sep 14, 2022; 28(34): 4959-4972
Published online Sep 14, 2022. doi: 10.3748/wjg.v28.i34.4959
Published online Sep 14, 2022. doi: 10.3748/wjg.v28.i34.4959
Figure 1 Remission and steroid-free remission rates in cytapheresis therapy in patients with ulcerative colitis concomitantly treated with thiopurines or immunomodulators.
Box plot shows that, in cytapheresis therapy, the remission rates range from 40.3%-73% (mean: 56.25%, median: 55.85%, interquartile range: 41.475%-71.425%) and the rates of steroid-free remission range from 36%-56.3% (mean: 47.25%, median: 48.35%, interquartile range: 37.425%-55.975%).
- Citation: Iizuka M, Etou T, Sagara S. Efficacy of cytapheresis in patients with ulcerative colitis showing insufficient or lost response to biologic therapy. World J Gastroenterol 2022; 28(34): 4959-4972
- URL: https://www.wjgnet.com/1007-9327/full/v28/i34/4959.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i34.4959